Brannan Jamie
Known title: Executive Vice PresidentCIK: 0001952582
Associated companies
Transaction History
| ZTS | ▼ Sell | Tax Withholding | 566 | $72K | 2/19/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,204 | — | 2/19/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 380 | — | 2/8/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 179 | $23K | 2/8/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 529 | — | 2/6/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 249 | $32K | 2/6/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 374 | — | 2/8/2025 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 176 | $30K | 2/8/2025 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 289 | — | 2/8/2025 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 137 | $23K | 2/8/2025 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 521 | — | 2/6/2025 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 246 | $43K | 2/6/2025 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 208 | — | 2/10/2024 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 99 | $20K | 2/10/2024 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 313 | — | 2/10/2024 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 148 | $29K | 2/10/2024 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 370 | — | 2/8/2024 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 175 | $34K | 2/8/2024 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 102 | $16K | 2/11/2023 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 216 | — | 2/11/2023 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 175 | — | 2/11/2023 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 83 | $13K | 2/11/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Goldman Sachs initiates Zoetis coverage with Neutral rating
Goldman Sachs began covering Zoetis with a Neutral rating and a $74 price target. This follows recent guidance cuts that the market initially shrugged off, alongside a new board appointment. The stock currently trades near a key support level, with an RSI of 71.0 indicating strong recent momentum.
Goldman Sachs initiates Zoetis coverage with Neutral rating. Goldman Sachs began covering Zoetis with a Neutral rating and a $74 price target. This follows recent guidance cuts that the market initially shrugged off, alongside a new board appointment. The stock currently trades near a key support level, with an RSI of 71.0 indicating strong recent momentum.